These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 375958)

  • 21. Atenolol and sustained release nifedipine alone and in combination in hypertension. A randomised, double-blind, crossover study.
    Anderton JL; Vallance BD; Stanley NN; Crowe PF; Mittra B; Perks WH
    Drugs; 1988; 35 Suppl 4():22-6. PubMed ID: 3288467
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Hypertensive therapy. Improvement of compliance with a daily regimen of a two-drug combination].
    Otter HP
    ZFA (Stuttgart); 1982 Mar; 58(9):533-6. PubMed ID: 7080657
    [No Abstract]   [Full Text] [Related]  

  • 23. Controlled clinical trial of cadralazine as a second-step drug in the treatment of hypertension.
    Catalano M; Parini J; Romano M; Libretti A
    Eur J Clin Pharmacol; 1985; 28(2):135-8. PubMed ID: 3886402
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Trial of Antihypertensive Interventions and Management (TAIM) Study. Final results with regard to blood pressure, cardiovascular risk, and quality of life.
    Wassertheil-Smoller S; Oberman A; Blaufox MD; Davis B; Langford H
    Am J Hypertens; 1992 Jan; 5(1):37-44. PubMed ID: 1736933
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Treatment of hypertensive hyperuricemic patients with a new beta blocker-diuretic combination].
    Brandstetter G; Hoffmann H
    Wien Klin Wochenschr; 1984 Sep; 96(18):696-9. PubMed ID: 6240831
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy and safety of bisoprolol and atenolol in patients with mild to moderate hypertension: a double-blind, parallel group international multicentre study.
    Lithell H; Selinus I; Hosie J; Frithz G; Weiner L
    Eur Heart J; 1987 Dec; 8 Suppl M():55-64. PubMed ID: 2967186
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of atenolol and propranolol when added to long-term antihypertensive diuretic therapy.
    van Rooijen GJ; Boer P; Dorhout Mees EJ; Geyskes GG
    Clin Pharmacol Ther; 1979 Oct; 26(4):420-7. PubMed ID: 487688
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of the antihypertensive effects of betaxolol and chlorthalidone as monotherapy and in combination.
    Burris JF; Davidov ME; Jenkins P; Rofman B; Ginsberg D; Rosenbaum R; Ryan JR; Jain AK; Mroczek WJ
    Arch Intern Med; 1989 Nov; 149(11):2437-41. PubMed ID: 2684073
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical evaluation of atenolol in hypertensive patients.
    Ibrahim MM; Mossallam R
    Circulation; 1981 Aug; 64(2):368-74. PubMed ID: 7249304
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Assessment of a fixed-dosage combination of atenolol and chlorthalidone (Tenoretic) in hypertensive Nigerians.
    Salako LA; Falase AO; Aderounmu AF; Walker O
    Afr J Med Med Sci; 1990 Mar; 19(1):57-61. PubMed ID: 2109522
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Treatment of arterial hypertension: comparative study of atenolol + chlorthalidone vs. timolol maleate-hydrochlorthiazide-amiloride association].
    Brandão AP; Oigman W; Albanesi Filho FM
    Arq Bras Cardiol; 1981 Dec; 37(6):495-8. PubMed ID: 7347202
    [No Abstract]   [Full Text] [Related]  

  • 32. Atenolol plus nifedipine for mild to moderate systemic hypertension after fixed doses of either agent alone.
    Daniels AR; Opie LH
    Am J Cardiol; 1986 Apr; 57(11):965-70. PubMed ID: 3515899
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Atenolol and chlorthalidone administered alone and in combination for essential hypertension.
    Boike SC; Durley Y; Cubberley RB
    Clin Pharm; 1982; 1(5):449-53. PubMed ID: 6764166
    [No Abstract]   [Full Text] [Related]  

  • 34. Comparison of once daily atenolol, nitrendipine and their combination in mild to moderate essential hypertension.
    Maclean D; Mitchell ET; Lewis R; Irvine N; McLay JS; McEwen J; Coulson RR; Slater ND; Fitzsimons TJ; McDevitt DG
    Br J Clin Pharmacol; 1990 Apr; 29(4):455-63. PubMed ID: 2183868
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of atenolol and reserpine on selected events in the systolic hypertension in the elderly program (SHEP).
    Kostis JB; Berge KG; Davis BR; Hawkins CM; Probstfield J
    Am J Hypertens; 1995 Dec; 8(12 Pt 1):1147-53. PubMed ID: 8998247
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A randomized double-blind study of atenolol and celiprolol in mild to moderate hypertension.
    Silke B; Rosenthal F; Taylor S
    J Cardiovasc Pharmacol; 1986; 8 Suppl 4():S122-6. PubMed ID: 2427841
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Atenolol in essential hypertension.
    Myers MG; Lewis GR; Steiner J; Dollery CT
    Clin Pharmacol Ther; 1976 May; 19(5 Pt 1):502-7. PubMed ID: 776487
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A controlled study on the anti-hypertensive effect of a new beta-adrenoreceptor-blocking drug, metoprolol, in combination with chlorthalidone.
    Jäättelä A; Pyörälä K
    Clin Sci Mol Med Suppl; 1976 Dec; 3():521s-523s. PubMed ID: 799561
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ambulatory blood pressure during once-daily randomised double-blind administration of atenolol, metoprolol, pindolol, and slow-release propranolol.
    Floras JS; Jones JV; Hassan MO; Sleight P
    Br Med J (Clin Res Ed); 1982 Nov; 285(6352):1387-92. PubMed ID: 6814568
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A 16-week, randomized, double-blind, placebo-controlled, crossover trial to quantify the combined effect of an angiotensin-converting enzyme inhibitor and a beta-blocker on blood pressure reduction.
    Wald DS; Law M; Mills S; Bestwick JP; Morris JK; Wald NJ
    Clin Ther; 2008 Nov; 30(11):2030-9. PubMed ID: 19108791
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.